Literature DB >> 22773607

CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.

Sara Pelucchi1, Raffaella Mariani, Stefano Calza, Anna Ludovica Fracanzani, Giulia Litta Modignani, Francesca Bertola, Fabiana Busti, Paola Trombini, Mirella Fraquelli, Gian Luca Forni, Domenico Girelli, Silvia Fargion, Claudia Specchia, Alberto Piperno.   

Abstract

BACKGROUND: Most patients with hereditary hemochromatosis in the Caucasian population are homozygous for the p.C282Y mutation in the HFE gene. The penetrance and expression of hereditary hemochromatosis differ largely among cases of homozygous p.C282Y. Genetic factors might be involved in addition to environmental factors. DESIGN AND METHODS: In the present study, we analyzed 50 candidate genes involved in iron metabolism and evaluated the association between 214 single nucleotide polymorphisms in these genes and three phenotypic outcomes of iron overload (serum ferritin, iron removed and transferrin saturation) in a large group of 296 p.C282Y homozygous Italians. Polymorphisms were tested for genetic association with each single outcome using linear regression models adjusted for age, sex and alcohol consumption.
RESULTS: We found a series of 17 genetic variants located in different genes with possible additive effects on the studied outcomes. In order to evaluate whether the selected polymorphisms could provide a predictive signature for adverse phenotype, we re-evaluated data by dividing patients in two extreme phenotype classes based on the three phenotypic outcomes. We found that only a small improvement in prediction could be achieved by adding genetic information to clinical data. Among the selected polymorphisms, a significant association was observed between rs3806562, located in the 5'UTR of CYBRD1, and transferrin saturation. This variant belongs to the same haplotype block that contains the CYBRD1 polymorphism rs884409, found to be associated with serum ferritin in another population of p.C282Y homozygotes, and able to modulate promoter activity. A luciferase assay indicated that rs3806562 does not have a significant functional role, suggesting that it is a genetic marker linked to the putative genetic modifier rs884409.
CONCLUSIONS: While our results support the hypothesis that polymorphisms in genes regulating iron metabolism may modulate penetrance of HFE-hereditary hemochromatosis, with emphasis on CYBRD1, they strengthen the notion that none of these polymorphisms alone is a major modifier of the phenotype of hereditary hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773607      PMCID: PMC3590088          DOI: 10.3324/haematol.2012.062661

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  39 in total

1.  Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis.

Authors:  S Distante; M Elmberg; K B Foss Haug; R Ovstebø; J P Berg; P Kierulf; R Hultcrantz; H Bell
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

2.  The role of iron in the regulation of hepatic transferrin synthesis.

Authors:  A G Morton; A S Tavill
Journal:  Br J Haematol       Date:  1977-07       Impact factor: 6.998

3.  Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis.

Authors:  W J Griffiths; W S Sly; T M Cox
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

5.  Genes that modify the hemochromatosis phenotype in mice.

Authors:  J E Levy; L K Montross; N C Andrews
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.

Authors:  P L Lee; T Gelbart; C West; C Halloran; V Felitti; E Beutler
Journal:  Blood Cells Mol Dis       Date:  2001 Sep-Oct       Impact factor: 3.039

7.  Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening.

Authors:  Peter W Whiting; Linda M Fletcher; Jeanette K Dixon; Peter Gochee; Lawrie W Powell; Darrell H G Crawford
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

8.  HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype.

Authors:  Sandrine Jacolot; Gerald Le Gac; Virginie Scotet; Isabelle Quere; Catherine Mura; Claude Ferec
Journal:  Blood       Date:  2003-12-11       Impact factor: 22.113

9.  Multigenic control of hepatic iron loading in a murine model of hemochromatosis.

Authors:  Mounia Bensaid; Séverine Fruchon; Christine Mazères; Seiamak Bahram; Marie-Paule Roth; Hélène Coppin
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

10.  A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.

Authors:  Clare C Constantine; Greg J Anderson; Chris D Vulpe; Christine E McLaren; Melanie Bahlo; Heng Lin Yeap; Dorota M Gertig; Nicholas J Osborne; Nadine A Bertalli; Kenneth B Beckman; Victoria Chen; Pavel Matak; Andrew T McKie; Martin B Delatycki; John K Olynyk; Dallas R English; Melissa C Southey; Graham G Giles; John L Hopper; Katrina J Allen; Lyle C Gurrin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

View more
  13 in total

1.  Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice.

Authors:  Constance Delaby; Vincent Oustric; Caroline Schmitt; Francoise Muzeau; Anne-Marie Robreau; Philippe Letteron; Eric Couchi; Angel Yu; Saïd Lyoumi; Jean-Charles Deybach; Herve Puy; Zoubida Karim; Carole Beaumont; Bernard Grandchamp; Peter Demant; Laurent Gouya
Journal:  Mamm Genome       Date:  2013-12       Impact factor: 2.957

2.  A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.

Authors:  S Noci; M Dugo; F Bertola; F Melotti; A Vannelli; T A Dragani; A Galvan
Journal:  Pharmacogenomics J       Date:  2015-05-12       Impact factor: 3.550

Review 3.  Molecular mediators governing iron-copper interactions.

Authors:  Sukru Gulec; James F Collins
Journal:  Annu Rev Nutr       Date:  2014-06-02       Impact factor: 11.848

Review 4.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

5.  Examining the clinical use of hemochromatosis genetic testing.

Authors:  Matthew B Lanktree; Bruce B Lanktree; Guillaume Paré; John S Waye; Bekim Sadikovic; Mark A Crowther
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

6.  Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.

Authors:  Christine E McLaren; Mary J Emond; V Nathan Subramaniam; Pradyumna D Phatak; James C Barton; Paul C Adams; Justin B Goh; Cameron J McDonald; Lawrie W Powell; Lyle C Gurrin; Katrina J Allen; Deborah A Nickerson; Tin Louie; Grant A Ramm; Gregory J Anderson; Gordon D McLaren
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

Review 7.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

Review 8.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

Review 9.  Pathophysiological consequences and benefits of HFE mutations: 20 years of research.

Authors:  Ina Hollerer; André Bachmann; Martina U Muckenthaler
Journal:  Haematologica       Date:  2017-03-09       Impact factor: 9.941

10.  Whole genome sequencing of one complex pedigree illustrates challenges with genomic medicine.

Authors:  Han Fang; Yiyang Wu; Hui Yang; Margaret Yoon; Laura T Jiménez-Barrón; David Mittelman; Reid Robison; Kai Wang; Gholson J Lyon
Journal:  BMC Med Genomics       Date:  2017-02-23       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.